Safety and efficacy of postoperative enoxaparin treatment in patients undergoing curative hepatobiliary-pancreatic cancer surgery: a prospective, Phase Two, multi-center study

Safety and efficacy of postoperative enoxaparin treatment in patients undergoing curative hepatobiliary-pancreatic cancer surgery: a prospective, Phase Two, multi-center study - Safety and efficacy of postoperative enoxaparin treatment in patients undergoing curative hepatobiliary-pancreatic cancer surgery: a prospective, Phase Two, multi-center study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019368

Enrollment

260

Registered

2015-10-15

Start date

2015-03-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatobiliary-pancreatic cancer

Interventions

Enoxaparin treatment for 8 days Physiotherapy only

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Surgery for hepato-biliary pancreatic surgery

Exclusion criteria

Exclusion criteria: Pancreatic Head Resection Major Hepatectomy with bile duct reconstruction

Design outcomes

Primary

Measure	Time frame
Efficacy of postoperative enoxaparin treatment Assess between POD 7 to POD 11	—

Countries

Japan

Contacts

Public ContactKoichi Kawamoto

Osaka University Graduate School of Medicine Department of Surgery

kkawamoto@gesurg.med.osaka-u.ac.jp06-6879-3251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026